614
Views
16
CrossRef citations to date
0
Altmetric
Review

Hepatocyte cell therapy in liver disease

&

References

  • Williams R. Global challenges in liver disease. Hepatology 2006;44(3):521-6
  • Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure. Lancet 2010;376(9736):190-201
  • O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342(8866):273-5
  • McKiernan P. Liver transplantation and cell therapies for inborn errors of metabolism. J Inherit Metab Dis 2013;36(4):675-80
  • Starzl TE, Marchioro TL, Vonkaulla KN, et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659-76
  • NHS Blood and Transplant. Transplant Activity in the UK. 2011. Available from: www.organdonation.nhs.uk/ukt/statistics/transplant_activity_report/transplant_activity_report.asp [Last accessed 04 July 2012]
  • Lee SW, Wang X, Chowdhury NR, et al. Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles. Ann Hepatol 2004;3(2):48-53
  • Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 1965;162(3):329-45
  • Matas AJ, Sutherland DE, Steffes MW, et al. Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 1976;192(4242):892-4
  • Sgroi A, Serre-Beinier V, Morel P, et al. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation 2009;87(4):457-66
  • Kiley JE, Pender JC, Welch HF, et al. Ammonia intoxication treated by hemodialysis. N Engl J Med 1958;259(24):1156-61
  • Burnell JM, Dawborn JK, Epstein RB, et al. Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med 1967;276(17):935-43
  • Trey C, Burns DG, Saunders SJ. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966;274(9):473-81
  • Sabin S, Merritt JA. Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange). Ann Intern Med 1968;68(1):1-7
  • Chang TM. Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma. Lancet 1972;2(7791):1371-2
  • Gazzard BG, Willison RA, Weston MJ, et al. Charcoal haemoperfusion for paracetamol overdose. Br J Clin Pharmacol 1974;1(3):271-5
  • Gazzard BG, Weston MJ, Murray-Lyon IM, et al. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974;1(7870):1301-7
  • Nyberg SL, Peshwa MV, Payne WD, et al. Evolution of the bioartificial liver: the need for randomized clinical trials. Am J Surg 1993;166(5):512-21
  • Yu Y, Fisher JE, Lillegard JB, et al. Cell therapies for liver diseases. Liver Transpl 2012;18(1):9-21
  • Mazaris EM, Roussos CT, Papalois VE. Hepatocyte transplantation: a review of worldwide clinical developments and experiences. Exp Clin Transplant 2005;3(1):306-15
  • Gewartowska M, Olszewski WL. Hepatocyte transplantation-biology and application. Ann Transplant 2007;12(1):27-36
  • Rosner G, Oren R, Halpern Z, et al. Anoikis mechanisms during hepatocyte isolation. Hepatology 2002;36(4):467A
  • Zvibel I, Smets F, Soriano H. Anoikis: Roadblock to cell transplantation? Cell Transplant 2002;11(7):621-30
  • Newsome PN, Tsiaoussis J, Masson S, et al. Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology 2004;40(3):636-45
  • Demetriou AA, Levenson SM, Novikoff PM, et al. Survival, organization, and function of microcarrier-attached hepatocytes transplanted in rats. Proc Natl Acad Sci U S A 1986;83(19):7475-9
  • Demetriou AA, Whiting JF, Feldman D, et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986;233(4769):1190-2
  • Hughes RD, Mitry RR, Dhawan A. Current status of hepatocyte transplantation. Transplantation 2012;93(4):342-7
  • Kazemnejad S. Hepatic tissue engineering using scaffolds: state of the art. Avicenna J Med Biotechnol 2009;1(3):135-45
  • Zhou Q, Li L, Li J. Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications. Liver Int 2015;35(3):687-94
  • Mei J, Sgroi A, Mai G, et al. Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Cell Transplant 2009;18(1):101-10
  • Jitraruch S, Dhawan A, Hughes RD, et al. Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure. PLoS One 2014;9(12):e113609
  • Liu T, Wang Y, Tai G, et al. Could co-transplantation of iPS cells derived hepatocytes and MSCs cure end-stage liver disease? Cell Biol Int 2009;33(11):1180-3
  • Fitzpatrick E, Wu Y, Dhadda P, et al. Coculture with mesenchymal stem cells results in improved viability and function of human hepatocytes. Cell Transplant 2015;24(1):73-83
  • Yamanouchi K, Zhou H, Roy-Chowdhury N, et al. Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology 2009;49(1):258-67
  • Guha C, Parashar B, Deb NJ, et al. Liver irradiation: a potential preparative regimen for hepatocyte transplantation. Int J Radiat Oncol Biol Phys 2001;49(2):451-7
  • Krause P, Wolff HA, Rave-Frank M, et al. Fractionated external beam radiotherapy as a suitable preparative regimen for hepatocyte transplantation after partial hepatectomy. Int J Radiat Oncol Biol Phys 2011;80(4):1214-19
  • Jorns C, Ellis EC, Nowak G, et al. Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med 2012;272(3):201-23
  • Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999;19(1):39-48
  • Strom SC, Fisher RA, Thompson MT, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997;63(4):559-69
  • Wang F, Zhou L, Ma X, et al. Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study. Transplant Proc 2014;46(1):192-8
  • Gramignoli R, Vosough M, Kannisto K, et al. Clinical hepatocyte transplantation: practical limits and possible solutions. Eur Surg Res 2015;54(3-4):162-77
  • Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation 2006;82(4):441-9
  • Panackel C, Thomas R, Sebastian B, et al. Recent advances in management of acute liver failure. Indian J Crit Care Med 2015;19(1):27-33
  • Strain AJ, Neuberger JM. A bioartificial liver–state of the art. Science 2002;295(5557):1005-9
  • Sauer IM, Gerlach JC. Modular extracorporeal liver support. Artif Organs 2002;26(8):703-6
  • Sauer IM, Kardassis D, Zeillinger K, et al. Clinical extracorporeal hybrid liver support–phase I study with primary porcine liver cells. Xenotransplantation 2003;10(5):460-9
  • Sauer IM, Zeilinger K, Obermayer N, et al. Primary human liver cells as source for modular extracorporeal liver support–a preliminary report. Int J Artif Organs 2002;25(10):1001-5
  • Sussman NL, Gislason GT, Conlin CA, et al. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994;18(5):390-6
  • Millis JM, Cronin DC, Johnson R, et al. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation 2002;74(12):1735-46
  • van de Kerkhove MP, di Florio E, Scuderi V, et al. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs 2002;25(10):950-9
  • van de Kerkhove MP, di Florio E, Scuderi V, et al. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. Cell Transplant 2003;12(6):563-8
  • Rozga J, Podesta L, Lepage E, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994;219(5):538-44
  • Mullon C, Pitkin Z. The HepatAssist bioartificial liver support system: clinical study and pig hepatocyte process. Expert Opin Investig Drugs 1999;8(3):229-35
  • Demetriou AA, Brown RSJr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239(5):660-7
  • Puppi J, Strom SC, Hughes RD, et al. Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 2012;21(1):1-10
  • Dhawan A, Puppi J, Hughes RD, et al. Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010;7(5):288-98
  • Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 1969;43(3):506-20
  • Shields PL, Morland CM, Salmon M, et al. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999;163(11):6236-43
  • Abuzakouk M, Feighery C, O’Farrelly C. Collagenase and dispase enzymes disrupt lymphocyte surface molecules. J Immunol Methods 1996;194(2):211-16
  • Stephenne X, Debray FG, Smets F, et al. Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria. Cell Transplant 2012;21(12):2765-70
  • Bhogal RH, Hodson J, Bartlett DC, et al. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 2011;6(3):e18222
  • Atkinson MC. The use of N-acetylcysteine in intensive care. Crit Care Resusc 2002;4(1):21-7
  • Zwingmann C, Bilodeau M. Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology 2006;43(3):454-63
  • Donini A, Baccarani U, Lavaroni S, et al. Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation. Transplant Proc 2001;33(1-2):1972-3
  • Sagias FG, Mitry RR, Hughes RD, et al. N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. Cell Transplant 2010;19(11):1487-92
  • Bartlett DC, Hodson J, Bhogal RH, et al. Combined use of N-acetylcysteine and liberase improves the viability and metabolic function of human hepatocytes isolated from human liver. Cytotherapy 2014;16(6):800-9
  • Sosef MN, De Bondt RB, Bosma A, et al. The fate of autologous hepatocytes transplanted into spleen, pancreas, mesentery, stomach, and small bowel wall in pigs. HPB (Oxford) 2007;9(3):216-18
  • Grossman M, Raper SE, Wilson JM. Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity. Hum Gene Ther 1992;3(5):501-10
  • Raper SE, Grossman M, Rader DJ, et al. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg 1996;223(2):116-26
  • Schwarz A, Lindl T, Hohneke C, et al. Human autologous liver cell transplantation for the treatment of cirrhosis. The Internet Journal of Gastroenterology 2009;10:1
  • Nguyen TH, Ferry N. Liver gene therapy: advances and hurdles. Gene Ther 2004;11(Suppl 1):S76-84
  • Nguyen TH, Mainot S, Lainas P, et al. Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors. Curr Gene Ther 2009;9(2):136-49
  • Baccarani U, Sanna A, Cariani A, et al. Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience. Liver Transpl 2003;9(5):506-12
  • Baccarani U, Sanna A, Cariani A, et al. Cryopreserved human hepatocytes from cell bank: in vitro function and clinical application. Transplant Proc 2005;37(1):256-9
  • Stephenne X, Najimi M, Smets F, et al. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 2005;5(8):2058-61
  • Terry C, Dhawan A, Mitry RR, et al. Cryopreservation of isolated human hepatocytes for transplantation: State of the art. Cryobiology 2006;53(2):149-59
  • Stephenne X, Najimi M, Sokal EM. Hepatocyte cryopreservation: is it time to change the strategy? World J Gastroenterol 2010;16(1):1-14
  • Lilja H, Blanc P, Demetriou AA, et al. Response of cultured fetal and adult rat hepatocytes to growth factors and cyclosporine. Cell Transplant 1998;7(3):257-66
  • Bin WT, Ma LM, Xu Q, et al. Embryonic hepatocyte transplantation for hepatic cirrhosis: efficacy and mechanism of action. World J Gastroenterol 2012;18(4):309-22
  • Fiegel HC, Pryymachuk G, Rath S, et al. Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat. J Cell Mol Med 2010;14(1-2):267-74
  • Weber A, Touboul T, Mainot S, et al. Human foetal hepatocytes: isolation, characterization, and transplantation. Methods Mol Biol 2010;640:41-55
  • Khan AA, Habeeb A, Parveen N, et al. Peritoneal transplantation of human fetal hepatocytes for the treatment of acute fatty liver of pregnancy: a case report. Trop Gastroenterol 2004;25(3):141-3
  • Habibullah CM, Syed IH, Qamar A, et al. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994;58(8):951-2
  • Gridelli B, Vizzini G, Pietrosi G, et al. Efficient human fetal liver cell isolation protocol based on vascular perfusion for liver cell-based therapy and case report on cell transplantation. Liver Transpl 2012;18(2):226-37
  • Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008;1782(2):61-74
  • Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008;322(5907):1490-4
  • Feldmann G. Liver transplantation of hepatic stem cells: potential use for treating liver diseases. Cell Biol Toxicol 2001;17(2):77-85
  • Schmelzer E, Wauthier E, Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 2006;24(8):1852-8
  • Haridass D, Yuan Q, Becker PD, et al. Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol 2009;175(4):1483-92
  • Touboul T, Hannan NR, Corbineau S, et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 2010;51(5):1754-65
  • Basma H, Soto-Gutierrez A, Yannam GR, et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009;136(3):990-9
  • Yee J. Turning Somatic Cells into Pluripotent Stem Cells. Nature Education 2010;3(9):25
  • Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol 2002;2(11):859-71
  • Drukker M. Immunogenicity of embryonic stem cells and their progeny. Methods Enzymol 2006;420:391-409
  • Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663-76
  • Sauer V, Roy-Chowdhury N, Guha C, et al. Induced pluripotent stem cells as a source of hepatocytes. Curr Pathobiol Rep 2014;2(1):11-20
  • Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010;51(1):297-305
  • Schwartz RE, Fleming HE, Khetani SR, et al. Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv 2014;32(2):504-13
  • Espejel S, Roll GR, McLaughlin KJ, et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010;120(9):3120-6
  • Nishimori M, Yakushiji H, Mori M, et al. Tumorigenesis in cells derived from induced pluripotent stem cells. Hum Cell 2014;27(1):29-35
  • Malecki M. ’Above all, do no harm’: safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis. Stem Cell Res Ther 2014;5(3):73
  • Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474(7350):212-15
  • Zhan Y, Wang Y, Wei L, et al. Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats. Transplant Proc 2006;38(9):3082-5
  • Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6(11):1229-34
  • Austin TW, Lagasse E. Hepatic regeneration from hematopoietic stem cells. Mech Dev 2003;120(1):131-5
  • Khurana S, Mukhopadhyay A. In vitro transdifferentiation of adult hematopoietic stem cells: an alternative source of engraftable hepatocytes. J Hepatol 2008;49(6):998-1007
  • Christ B, Stock P. Mesenchymal stem cell-derived hepatocytes for functional liver replacement. Front Immunol 2012;3:168
  • Wu XB, Tao R. Hepatocyte differentiation of mesenchymal stem cells. Hepatobiliary Pancreat Dis Int 2012;11(4):360-71
  • Aurich H, Sgodda M, Kaltwasser P, et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009;58(4):570-81
  • Stock P, Bruckner S, Ebensing S, et al. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat Protoc 2010;5(4):617-27
  • Pilat N, Unger L, Berlakovich GA. Implication for bone marrow derived stem cells in hepatocyte regeneration after orthotopic liver transplantation. Int J Hepatol 2013;2013:310612
  • Campard D, Lysy PA, Najimi M, et al. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008;134(3):833-48
  • Teramoto K, Asahina K, Kumashiro Y, et al. Hepatocyte differentiation from embryonic stem cells and umbilical cord blood cells. J Hepatobiliary Pancreat Surg 2005;12(3):196-202
  • Tang XP, Zhang M, Yang X, et al. Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro. World J Gastroenterol 2006;12(25):4014-19
  • Khademi F, Soleimani M, Verdi J, et al. Human endometrial stem cells differentiation into functional hepatocyte-like cells. Cell Biol Int 2014;38(7):825-34
  • Vaghjiani V, Vaithilingam V, Tuch B, et al. Deriving hepatocyte-like cells from placental cells for transplantation. Curr Stem Cell Res Ther 2013;8(1):15-24
  • Tee JY, Vaghjiani V, Liu YH, et al. Immunogenicity and immunomodulatory properties of hepatocyte-like cells derived from human amniotic epithelial cells. Curr Stem Cell Res Ther 2013;8(1):91-9
  • Vaghjiani V, Vaithilingam V, Saraswati I, et al. Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro. Stem Cells Dev 2014;23(8):866-76
  • Thomas JA, Forbes SJ. A fat chance for hepatocyte transplantation? Gut 2009;58(4):480-2
  • Strom S, Fisher R. Hepatocyte transplantation: new possibilities for therapy. Gastroenterology 2003;124(2):568-71
  • Nagata H, Ito M, Cai J, et al. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology 2003;124(2):422-31
  • Dooldeniya MD, Warrens AN. Xenotransplantation: where are we today? J R Soc Med 2003;96(3):111-17
  • Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002;295(5557):1089-92
  • Holmes BJ, Richards A, McLaughlin M, et al. Antibody responses in early graft rejection in pig-to-primate renal xenotransplantation. Transplant Proc 2001;33(1-2):717-18

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.